EUVIMEDEUVIMED entdecken
Crossref

Is Stimulated Thyroglobulin Before Radioiodine Therapy a Useful Tool in Predicting Response to Initial Therapy in Patients with Differentiated Thyroid Carcinoma?

Fabiana Jaeger, Laura Berton Eidt, Kamille Guidolin, Giullia Menuci Chianca Landenberger iD, Cristiane Bündchen, Lenara Golbert, Vanessa Suñé Mattevi, Erika Laurini de Souza Meyer iD

Hormone and Metabolic Research · 01.09.2024 · 56 (09) · 641-648

DOI: 10.1055/a-2318-5320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.09.2024. Verfasst von Fabiana Jaeger und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Iodine Radioisotopes, Thyroglobulin. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyroglobulin (Tg) is an important tool to evaluate the persistence and recurrence risk in differentiated thyroid cancer (DTC). We aimed to evaluate the correlation between pre-radioiodine therapy stimulated Tg (pre-RAI Tg) levels and the first response to treatment evaluation, and to establish a cut-off pre-RAI Tg threshold for predicting an initial excellent response. Retrospective cohort study of DTC patients who underwent total thyroidectomy and radioiodine therapy. Response to therapy was evaluated 6 to 24 months after initial therapy, and patients were classified as: excellent response (ER); indeterminate response (IndR) and incomplete response (IncR). Total patients: 166 among which 85.5% female with mean age of 47.6 ± 13 years. The ER had a significantly lower pre-RAI Tg in comparison to IndR (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsIodine RadioisotopesThyroglobulinHumansFemaleMiddle AgedMaleRetrospective StudiesTreatment OutcomeAdultPrognosisROC CurveThyroidectomy

Substanzen

Iodine RadioisotopesThyroglobulin

Autor:innen und Institutionen

  • Graduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
  • Endocrine Division, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil.
  • Núcleo de Apoio a Pesquisa - Nupesq, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
  • Internal Medicine, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.

ORCID-Profile: Giullia Menuci Chianca Landenberger, Erika Laurini de Souza Meyer

Zitieren

APA

Jaeger, F., Eidt, L. B., Guidolin, K., Landenberger, G. M. C., Bündchen, C., Golbert, L., Mattevi, V. S., & Meyer, E. L. S. (2024). Is Stimulated Thyroglobulin Before Radioiodine Therapy a Useful Tool in Predicting Response to Initial Therapy in Patients with Differentiated Thyroid Carcinoma?. Hormone and Metabolic Research, 56(09), 641-648. https://doi.org/10.1055/a-2318-5320

Vancouver

Jaeger F, Eidt LB, Guidolin K, Landenberger GMC, Bündchen C, Golbert L, et al. Is Stimulated Thyroglobulin Before Radioiodine Therapy a Useful Tool in Predicting Response to Initial Therapy in Patients with Differentiated Thyroid Carcinoma?. Hormone and Metabolic Research. 2024;56(09):641-648. doi:10.1055/a-2318-5320

BibTeX
@article{Jaeger2024,
  author = {Jaeger, Fabiana and Eidt, Laura Berton and Guidolin, Kamille and Landenberger, Giullia Menuci Chianca and Bündchen, Cristiane and Golbert, Lenara and Mattevi, Vanessa Suñé and Meyer, Erika Laurini de Souza},
  title = {Is Stimulated Thyroglobulin Before Radioiodine Therapy a Useful Tool in Predicting Response to Initial Therapy in Patients with Differentiated Thyroid Carcinoma?},
  journal = {Hormone and Metabolic Research},
  year = {2024},
  volume = {56},
  number = {09},
  pages = {641--648},
  doi = {10.1055/a-2318-5320}
}
Kostenlos starten →